Back

Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury

29 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Latest on STEMI Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Iwona Bil-Lula

Wroclaw Medical University, Wroclaw (Poland)

70 More presentations in this session

Presentation thumbnail
Doctor C. Guerreiro (Vila Nova de Gaia, PT)
Abstract
Presentation thumbnail
Doctor H. Tolppanen (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Professor M. Stockburger (Nauen, DE)
Abstract Slides
Presentation thumbnail
Doctor J. Roehnisch (Berlin, DE)
Abstract Slides
Presentation thumbnail
Mr Y. Minamimoto (Yokohama, JP)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Latest on STEMI

The Event

Event poster

ESC Congress 2017

29 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources